At the same time, by inhibiting TNFRSF10C competitively binding with tumor necrosis factor-associated apoptosis-inducing ligand (TRAIL), TRAIL-induced tumor cell apoptosis can be promoted, thus possibly inhibiting the proliferation and metastasis of tumor cells (Figures 6D,H). Here, TNFRSF10C is linked to neoplasm.